CORONADO BIOSCIENCES, INC. Common Stock (par value $0.001 per share) At Market Issuance Sales AgreementCoronado Biosciences Inc • April 29th, 2013 • Pharmaceutical preparations • New York
Company FiledApril 29th, 2013 Industry JurisdictionCoronado Biosciences, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC (“MLV”), as follows: